ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,121,701 | -57.5% | 1,300,221 | -33.4% | 0.01% | -54.2% |
| Q2 2023 | $9,705,317 | +4.7% | 1,952,780 | +4.1% | 0.02% | -7.7% |
| Q1 2023 | $9,271,140 | -8.5% | 1,876,749 | +16.5% | 0.03% | -18.8% |
| Q4 2022 | $10,134,775 | +12.7% | 1,611,252 | +93.4% | 0.03% | +3.2% |
| Q3 2022 | $8,996,000 | +396.2% | 832,964 | +423.6% | 0.03% | +416.7% |
| Q2 2022 | $1,813,000 | -79.1% | 159,078 | -83.3% | 0.01% | -76.9% |
| Q1 2022 | $8,692,000 | +206.9% | 954,164 | +402.7% | 0.03% | +333.3% |
| Q4 2021 | $2,832,000 | +246.2% | 189,791 | +505.2% | 0.01% | +200.0% |
| Q2 2021 | $818,000 | -88.0% | 31,359 | -83.7% | 0.00% | -88.9% |
| Q1 2021 | $6,797,000 | -21.6% | 192,538 | -44.0% | 0.02% | -28.0% |
| Q4 2020 | $8,673,000 | -36.9% | 343,624 | -5.8% | 0.02% | -49.0% |
| Q3 2020 | $13,751,000 | +26.7% | 364,648 | +43.9% | 0.05% | -9.3% |
| Q2 2020 | $10,850,000 | – | 253,393 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |